Despite a tiny domestic market size, the Lithuanian life sciences sector is full of hidden surprises. Comprising four percent of the nation’s entire GDP, with one percent accounted for by a burgeoning biotechnology sector, Lithuania can draw on a strong science R&D…
With an exit from a period of recession in 2017, a new era of change and positivity is underway in Brazil. Stakeholders from across the public and private sectors are pulling together through strategic partnerships and dialogues to increase both the quantity and quality of…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…
With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, Canadians still lack universal drug coverage and Canadian health innovation has lagged behind that of the world leaders in this area. This report…
With an admirable legacy of excellence behind it, Austria’s healthcare and life science industry is poised to take the next step and help make the country a genuine hub for both its region and for Europe. Vienna is already fast establishing itself as Central…
Squirreled away right on the South-Eastern fringe of Europe, Bulgaria still has a tendency to be overlooked and underestimated by the uninitiated. Not so by the international pharmaceuticals industry, however, which has long considered what is one of the EU’s most recent…
Transitioning out of a period of instability following the revolution of 2011, Tunisia has much to recommend it within its region. Comparative political stability and a geostrategic location as the northerly most country in Africa are helping turn the Arab world’s only…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the ecosystem of pharmaceutical companies in Ukraine, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, the…
With steady GDP growth, political stability and the best healthcare system in Latin America, Colombia’s life sciences industry has all the ingredients for success laid out before it. Indeed, with the domestic pharmaceutical market set to grow at a rate of around 7.3…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Hong Kong, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies in Indonesia, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…